RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact
-
- Marco Volante
- Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
-
- Ida Rapa
- Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
-
- Manoj Gandhi
- Department of Pathology (M.G., Y.E.N.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260
-
- Gianni Bussolati
- Department of Biomedical Sciences and Human Oncology (G.B.), University of Turin, 10126 Turin, Italy
-
- Daniela Giachino
- Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
-
- Mauro Papotti
- Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
-
- Yuri E. Nikiforov
- Department of Pathology (M.G., Y.E.N.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260
収録刊行物
-
- The Journal of Clinical Endocrinology & Metabolism
-
The Journal of Clinical Endocrinology & Metabolism 94 (12), 4735-4741, 2009-12-01
The Endocrine Society